• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset

Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset

by Truveta staff | Apr 25, 2024 | Data, News

Today, we are excited to announce the largest and most complete mother-child electronic health record (EHR) dataset for scientifically rigorous research on mothers and their children. Truveta empowers researchers with unparalleled insights into the continuum of care...
Truveta awarded real-world data contract by the CDC to study COVID, maternal health, and pediatric care

Truveta awarded real-world data contract by the CDC to study COVID, maternal health, and pediatric care

by Truveta staff | Jan 22, 2024 | News

Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S. Centers for Disease Control and Prevention (CDC) for privacy-preserving record linkage of patient-level real-world healthcare data....
10 Truveta Research insights & publications of 2023

10 Truveta Research insights & publications of 2023

by Truveta staff | Dec 15, 2023 | Research

As 2023 draws to a close and we reflect on a busy and exciting year for Truveta, something that stands out is the breadth and depth of research Truveta Research has been able to produce using Truveta Data and Truveta Studio. From studying new Alzheimer’s disease...
Moving from maternal health research to action

Moving from maternal health research to action

by Truveta Research | Aug 23, 2023 | Research, Research Insights

The United States has some of the highest rates of adverse maternal health outcomes compared to other high-income countries (Creanga et al., 2015; Gunja et al., 2022; Taylor et al., 2022). These outcomes have only increased in the last decade (Hoyert, 2023; U.S....
New research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19

New research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19

by Truveta staff | Jul 28, 2023 | Research

Scientists from the Institute for Systems Biology (ISB) have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute of Health (NIH) recommendation for prophylactic anticoagulant use for pregnant patients...
« Older Entries

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice